- Home
- DMRC vs TARA Comparison
DMRC vs TARA Comparison
Compare DMRC & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMRC
- TARA
- Stock Information
- Founded
- DMRC 2008
- TARA N/A
- Country
- DMRC United States
- TARA United States
- Employees
- DMRC N/A
- TARA N/A
- Industry
- DMRC EDP Services
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DMRC Technology
- TARA Health Care
- Exchange
- DMRC Nasdaq
- TARA Nasdaq
- Market Cap
- DMRC 219.0M
- TARA 196.8M
- IPO Year
- DMRC N/A
- TARA N/A
- Fundamental
- Price
- DMRC $10.14
- TARA $5.19
- Analyst Decision
- DMRC Strong Buy
- TARA Strong Buy
- Analyst Count
- DMRC 1
- TARA 6
- Target Price
- DMRC $30.00
- TARA $19.80
- AVG Volume (30 Days)
- DMRC 159.7K
- TARA 533.4K
- Earning Date
- DMRC 10-30-2025
- TARA 11-11-2025
- Dividend Yield
- DMRC N/A
- TARA N/A
- EPS Growth
- DMRC N/A
- TARA N/A
- EPS
- DMRC N/A
- TARA N/A
- Revenue
- DMRC $35,479,000.00
- TARA N/A
- Revenue This Year
- DMRC N/A
- TARA N/A
- Revenue Next Year
- DMRC N/A
- TARA N/A
- P/E Ratio
- DMRC N/A
- TARA N/A
- Revenue Growth
- DMRC N/A
- TARA N/A
- 52 Week Low
- DMRC $7.77
- TARA $1.80
- 52 Week High
- DMRC $48.32
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- DMRC 56.37
- TARA 58.47
- Support Level
- DMRC $9.19
- TARA $5.02
- Resistance Level
- DMRC $10.43
- TARA $5.32
- Average True Range (ATR)
- DMRC 0.60
- TARA 0.33
- MACD
- DMRC 0.15
- TARA -0.10
- Stochastic Oscillator
- DMRC 87.95
- TARA 28.44
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).